Icon

PRESTALIA (nda205003)- (EQ 2.5MG BASE;3.5MG,EQ 5MG BASE;7MG,EQ 10MG BASE;14MG)

AMLODIPINE BESYLATE; PERINDOPRIL ARGININE ADHERA
EQ 2.5MG BASE;3.5MG,EQ 5MG BASE;7MG,EQ 10MG BASE;14MG
No Yes
2029-Oct-05 Expired
None 2018-Jan-21
None No
Prestalia is a combination of perindopril, an angiotensin converting enzyme inhibitor, and amlodipine, a dihydropyridine calcium channel blocker, indicated for the treatment of hypertension to lower blood pressure: • In patients not adequately controlled with monotherapy. • As initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 2.5MG BASE;3.5MG ** ** - - -
EQ 5MG BASE;7MG ** ** - - -
EQ 10MG BASE;14MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.